☰

Samantha L. Gadd, Ph.D. - Publications

Affiliations: 
2001 West Virginia University, Morgantown, WV, United States 
Area:
Biochemistry, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Gadd S, Huff V, Skol AD, Renfro LA, Fernandez CV, Mullen EA, Jones CD, Hoadley KA, Yap KL, Ramirez NC, Aris S, Phung QH, Perlman EJ. Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. Cell Reports. Medicine. 100644. PMID 35617957 DOI: 10.1016/j.xcrm.2022.100644  0.384
2022 Tomita Y, Shimazu Y, Somasundaram A, Tanaka Y, Takata N, Ishi Y, Gadd S, Hashizume R, Angione A, Pinero G, Hambardzumyan D, Brat DJ, Hoeman CM, Becher OJ. A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M. Glia. PMID 35524725 DOI: 10.1002/glia.24189  0.313
2022 Dhar S, Gadd S, Patel P, Vaynshteyn J, Raju GP, Hashizume R, Brat DJ, Becher OJ. A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis. Acta Neuropathologica Communications. 10: 47. PMID 35395831 DOI: 10.1186/s40478-022-01336-5  0.418
2019 Ortiz MV, Ahmed S, Burns M, Henssen AG, Hollmann TJ, MacArthur I, Gunasekera S, Gaewsky L, Bradwin G, Ryan J, Letai A, He Y, Naranjo A, Chi YY, LaQuaglia M, ... ... Gadd S, et al. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor. Jci Insight. 4. PMID 31391345 DOI: 10.1172/Jci.Insight.127098  0.455
2019 Hoeman CM, Cordero FJ, Hu G, Misuraca K, Romero MM, Cardona HJ, Nazarian J, Hashizume R, McLendon R, Yu P, Procissi D, Gadd S, Becher OJ. ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nature Communications. 10: 1023. PMID 30833574 DOI: 10.1038/S41467-019-08823-9  0.415
2018 Armstrong AE, Gadd S, Huff V, Gerhard DS, Dome JS, Perlman EJ. A unique subset of low-risk wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A children’s oncology group study Plos One. 13: 208936. PMID 30543698 DOI: 10.1371/Journal.Pone.0208936  0.477
2018 Bailey AW, Suri A, Chou PM, Pundy T, Gadd S, Raimondi SL, Tomita T, Sredni ST. Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB). Bioengineering (Basel, Switzerland). 5. PMID 30400339 DOI: 10.3390/Bioengineering5040096  0.441
2017 Gadd S, Huff V, Walz AL, Ooms AHAG, Armstrong AE, Gerhard DS, Smith MA, Auvil JMG, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Hermida LC, et al. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nature Genetics. PMID 28825729 DOI: 10.1038/Ng.3940  0.454
2017 Ortiz MV, Burns M, Eisenberg A, Ahmed S, Gaewsky L, Bradwin G, Cifani P, Henssen A, Macarthur I, LaQuaglia M, Letai A, Naranjo A, Gadd S, Chi Y, Dome J, et al. Abstract 708: Prohibitin is a prognostic marker of treatment failure and therapeutic target to block chemotherapy resistance in Wilms tumor Cancer Research. 77: 708-708. DOI: 10.1158/1538-7445.Am2017-708  0.447
2016 Marsden L, Jennings LJ, Gadd S, Yu M, Perlman EJ, Cajaiba MM. BRAF Exon 15 Mutations in Pediatric Renal Stromal Tumors: Prevalence in Metanephric Stromal Tumors. Human Pathology. PMID 27769870 DOI: 10.1016/J.Humpath.2016.09.025  0.457
2016 Ooms AH, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Ma Y, Zong Z, Mungall AJ, Moore RA, et al. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27702824 DOI: 10.1158/1078-0432.Ccr-16-0985  0.395
2016 Gooskens SL, Gadd S, Heuvel-Eibrink MMvd, Perlman EJ. BCOR internal tandem duplications in clear cell sarcoma of the kidney. Genes, Chromosomes and Cancer. 55: 549-550. PMID 26874462 DOI: 10.1002/Gcc.22353  0.302
2016 Gadd SL, Walz AL, Ooms AH, Huff V, Gerhard DS, Smith MA, Auvil JMG, Hermida L, Davidsen T, Gesuwan P, Meerzaman D, Ma Y, Marra MA, Dome JS, Mullighan CG, et al. Abstract LB-180: The genetic landscape of Wilms tumor Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-180  0.504
2015 Perlman EJ, Gadd S, Arold ST, Radhakrishnan A, Gerhard DS, Jennings L, Huff V, Guidry Auvil JM, Davidsen TM, Dome JS, Meerzaman D, Hsu CH, Nguyen C, Anderson J, Ma Y, et al. MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours. Nature Communications. 6: 10013. PMID 26635203 DOI: 10.1038/Ncomms10013  0.357
2015 Gooskens SL, Gadd S, Guidry Auvil JM, Gerhard DS, Khan J, Patidar R, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Mullighan CG, Ma J, Jennings LJ, et al. TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney. Oncotarget. PMID 26158413 DOI: 10.18632/oncotarget.4682  0.414
2015 Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, Guidry Auvil JM, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Bowlby R, Brooks D, et al. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell. 27: 286-97. PMID 25670082 DOI: 10.1016/J.Ccell.2015.01.003  0.479
2015 Walz A, Ooms A, Gadd S, Gerhard D, Smith M, Guidry Auvil J, Meerzaman D, Chen Q, Hsu C, Yan C, Nguyen C, Hu Y, Bowlby R, Brooks D, Ma Y, et al. Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors Cancer Cell. 27: 426. DOI: 10.1016/J.Ccell.2015.02.008  0.418
2012 Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, Breslow N, Jennings L, Green DM, Beckwith JB, Perlman EJ. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (New York, N.Y.). 14: 742-56. PMID 22952427 DOI: 10.1593/Neo.12714  0.436
2012 Gadd S, Beezhold P, Jennings L, George D, Leuer K, Huang CC, Huff V, Tognon C, Sorensen PH, Triche T, Coffin CM, Perlman EJ. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. The Journal of Pathology. 228: 119-30. PMID 22374738 DOI: 10.1002/Path.4010  0.35
2012 Gadd SL, Gerhard DS, Smith MA, Auvil JG, Huff V, Geller JI, Dome J, Huang C, Perlman EJ. Abstract 1439: Loss of expression of SWI/SNF subunits in high risk Wilms tumor is accompanied by global gene expression changes Cancer Research. 72: 1439-1439. DOI: 10.1158/1538-7445.Am2012-1439  0.496
2011 Sredni ST, Gadd S, Jafari N, Huang CC. A Parallel Study of mRNA and microRNA Profiling of Peripheral Blood in Young Adult Women. Frontiers in Genetics. 2: 49. PMID 22303345 DOI: 10.3389/Fgene.2011.00049  0.312
2011 Gadd SL, Perlman EJ. Abstract 68: Increased H3K27 trimethylation is associated with decreased expression of miRNAs and bivalently modified genes in rhabdoid tumors Cancer Research. 71: 68-68. DOI: 10.1158/1538-7445.Am2011-68  0.416
2011 Gadd SL, Huang C, Lu Y, Huff V, Perlman EJ. Abstract 5353: Comprehensive Ggnomic analysis of diffuse hyperplastic perilobar nephroblastomatosis (DHPLN) Cancer Research. 71: 5353-5353. DOI: 10.1158/1538-7445.Am2011-5353  0.428
2010 Gadd S, Sredni ST, Huang CC, Perlman EJ. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 724-38. PMID 20212451 DOI: 10.1038/Labinvest.2010.66  0.48
2009 Sredni ST, Gadd S, Huang CC, Breslow N, Grundy P, Green DM, Dome JS, Shamberger RC, Beckwith JB, Perlman EJ. Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6800-9. PMID 19903788 DOI: 10.1158/1078-0432.Ccr-09-0312  0.438
2009 Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1770-8. PMID 19208794 DOI: 10.1158/1078-0432.Ccr-08-1030  0.398
2002 Gadd SL, Hobbs G, Miller MR. Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicological Sciences : An Official Journal of the Society of Toxicology. 66: 233-43. PMID 11896290 DOI: 10.1093/Toxsci/66.2.233  0.443
1999 Harnagea-Theophilus E, Gadd SL, Knight-Trent AH, DeGeorge GL, Miller MR. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors. Toxicology and Applied Pharmacology. 155: 273-9. PMID 10079213 DOI: 10.1006/Taap.1998.8619  0.409
Show low-probability matches.